EPHA2 and pancreatic adenocarcinoma: In line with this, down regulation of receptor expression with EphA2-specific siRNA oligos retarded tumor growth in pancreatic adenocarcinoma-derived cells [46] and significantly reduces malignancy in glioma [47], non-small cell lung cancer (NSCLC; [48]), and breast cancer cells [49].